Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 2, 2013

Survey: Caregivers of Spouses/Partners with MS Study

  • MS Research Study and Reports
    /
Researchers at the University at Albany, SUNY are recruiting anyone who is the spouse/romantic partner of someone with MS to…
MS Research Study and Reports

February 2, 2013

Investigators Recruiting for Personalized T Cell Immunotherapy Study in Secondary-Progressive MS –

  • MS Research Study and Reports
    /
This study is currently recruiting participants. Verified November 2012 by Opexa Therapeutics, Inc. Study Purpose: The purpose of this study is…
MS Research Study and Reports

February 2, 2013

BG-12 (Biogen’s Oral) NOW has a Name: TECFIDERA

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Tecfidera (BG-12) awaits FDA decision .. January 31, 2013 Tecfidera (BG-12) is pending FDA decision on March 27, 2013. This…
MS Drug Therapies

February 1, 2013

Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule

  • Marketing
    /
An injectable treatment for relapsing-remitting MS (RRMS) designed to significantly reduce the dosing schedule typical of standard interferon drugs has…
Marketing

January 30, 2013

Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis

  • MS Research Study and Reports
    /
  • Myelin Repair
    /
Androgenic hormones could help treat multiple sclerosis Paris- Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study…
MS Research Study and Reports

January 30, 2013

Do you take LDN or have taken LDN and want to share your story?

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
PO Box 1083, Buxton Norwich NR10 5WY Telephone: 0844 41 45 295 Email: [email protected] Web: www.ldnresearhctrust.org www.ldnaware.org Contact: Linda Elesgood…
Alternative therapies and devices for Multiple Sclerosis (MS)

January 29, 2013

Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox

  • MRI
    /
  • Multiple Sclerosis
    /
January 28, 2013 By Peter Sergo, medwireNews Reporter Quantitative magnetic resonance imaging (MRI) can detect microstructural changes in the spinal cords of…
MRI

January 29, 2013

Biogen says MS drug reduces relapse rates in study

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Biogen says potential multiple sclerosis treatment reduces relapse rates in late-stage study Associated Press – Fri, Jan 25, 2013 WESTON, Mass. (AP)…
MS Drug Therapies

January 29, 2013

Genzyme: FDA will review Lemtrada, its drug candidate for relapsing MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
By Chris Reidy, Globe Staff Genzyme, now a Cambridge-based unit of French drug giant Sanofi SA., said Monday that the…
MS Drug Therapies

January 29, 2013

Sanofi Moves Closer to Multiple Sclerosis Drug Approval

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
By Brian Orelli |  January 28, 2013 |  Sanofi (NYSE: SNY  ) announced today that the Food and Drug Administration accepted its supplemental Biologics License Application requesting permission to…
MS Drug Therapies

Categories

Latest Blog Posts